The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative PD-1 antibody tislelizumab plus chemotherapy for locally advanced gastro-oesophageal junction cancer: A prospective, nonrandomized, open-label, phase II trial.
 
Run-Cong Nie
No Relationships to Disclose
 
Ya Ding
No Relationships to Disclose
 
Shu-Qiang Yuan
No Relationships to Disclose
 
Yuan-fang Li
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Yongming Chen
No Relationships to Disclose
 
Muyan Cai
No Relationships to Disclose
 
Xiao-wei Sun
No Relationships to Disclose
 
Desheng Weng
No Relationships to Disclose
 
Dandan Li
No Relationships to Disclose
 
Jingjing Zhao
No Relationships to Disclose
 
Xiaojiang Chen
No Relationships to Disclose
 
Yuanxiang Guan
No Relationships to Disclose
 
Luo Ma
No Relationships to Disclose
 
Haibo Qiu
No Relationships to Disclose
 
Zhi-wei Zhou
No Relationships to Disclose
 
Xiao-Shi Zhang
No Relationships to Disclose
 
Ying-bo Chen
No Relationships to Disclose